What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Internal medicine, Neuroendocrine tumors, Pathology, Cancer and Gastroenterology.
His Internal medicine study incorporates themes from Endocrinology, Surgery and Oncology.
He has included themes like Gastrointestinal tract and Pancreas in his Neuroendocrine tumors study.
James C. Yao combines subjects such as Cancer research, Angiogenesis and Vascular endothelial growth factor with his study of Cancer.
James C. Yao interconnects Fluorouracil and Octreotide in the investigation of issues within Gastroenterology.
The study incorporates disciplines such as Epidemiology and Incidence in addition to Telotristat ethyl.
His most cited work include:
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States (2896 citations)
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors (1972 citations)
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Neuroendocrine tumors, Oncology, Cancer and Everolimus.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Surgery.
Neuroendocrine tumors is a subfield of Pathology that James C. Yao explores.
His Oncology research is multidisciplinary, incorporating elements of Hepatocellular carcinoma, Colorectal cancer and Lung.
His Cancer research incorporates themes from Proportional hazards model and Incidence.
His Everolimus research is multidisciplinary, relying on both Progression-free survival, Phases of clinical research, Placebo, Sunitinib and PI3K/AKT/mTOR pathway.
He most often published in these fields:
- Internal medicine (62.79%)
- Neuroendocrine tumors (44.19%)
- Oncology (32.27%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (62.79%)
- Oncology (32.27%)
- Neuroendocrine tumors (44.19%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Neuroendocrine tumors, Gastroenterology and Hepatocellular carcinoma.
James C. Yao merges many fields, such as Internal medicine and In patient, in his writings.
His research in Neuroendocrine tumors intersects with topics in Incidence, Epidemiology, Clinical endpoint, Everolimus and Primary tumor.
His research integrates issues of Placebo and Endocrinology in his study of Everolimus.
His work deals with themes such as Nausea, Surgery, Cancer and Confidence interval, which intersect with Gastroenterology.
James C. Yao has researched Surgery in several fields, including Lung cancer and Telotristat ethyl.
Between 2016 and 2021, his most popular works were:
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. (873 citations)
- Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines (128 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Internal medicine, Neuroendocrine tumors, Gastroenterology, Oncology and Hazard ratio.
His study connects Surgery and Internal medicine.
His Surgery research incorporates themes from Lung cancer, Telotristat ethyl, Epidemiology and Incidence.
His Neuroendocrine tumors study integrates concerns from other disciplines, such as Tolerability, Pancreas, Everolimus, Pharmacodynamics and Pharmacology.
His Everolimus research includes elements of Placebo and Endocrinology.
His Gastroenterology study combines topics from a wide range of disciplines, such as Surgical oncology, Fluorouracil, Octreotide and Lymph node.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
